SUBSPECIALTY CERTIFICATION IN CLINICAL AND LABORATORY DERMATOLOGICAL IMMUNOLOGY

The requirements for subspecialty certification in Clinical and Laboratory Dermatological Immunology (CLDI) are as follows:

• Prerequisites
  • A currently valid, full and unrestricted license to practice medicine or osteopathy in either the United States or Canada. The candidate may be denied certification if his/her licensure has been revoked, suspended, restricted, or surrendered in any jurisdiction - or if the candidate is subject to adverse licensure proceedings.
  • Primary certification by the American Board of Dermatology and the satisfactory completion of at least one year of training in an accredited fellowship in Clinical and Laboratory Dermatological Immunology.

• Training
  Information concerning accredited training programs in Clinical and Laboratory Dermatological Immunology is available from the office of the American Board of Dermatology. As stated above, a minimum of one year of fulltime training in a Clinical and Laboratory Dermatological Immunology training program is required of all candidates (See "Essentials of Training"). It is the responsibility of directors of fellowships in Clnical and Laboratory Dermatological Immunology to make certain that their trainees file a preliminary registration form in the Board office by August 1st or within 30 days of the start of training.

• Examination
  Candidates who have satisfied the above requirements are eligible to apply to the Board to take the subspecialty certification examination in Clinical and Laboratory Dermatological Immunology.

• Appeals Process
  An appeals procedure similar to that described for the certification process in dermatology is available for candidates for subspecialty certification in Clinical and Laboratory Dermatological Immunology who were declared ineligible by the Board for Clinical and Laboratory Dermatological Immunology or who failed the subspecialty examination. Candidates submitting such appeals should contact the Board for current additional information.